LabCorp Appoints Senior Finance Executive Jeffrey A. Davis to Its Board of Directors

Current CFO of Qurate Retail Group and Former CFO of J. C. Penney Brings More Than 30 Years of Finance Experience Across Multiple Industries BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 26, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 19, 2019-- LabCorp (NYSE: LH) announced today that it has provided notice of its intention to redeem all of its outstanding Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) for cash on Dec.

LabCorp Prices $400,000,000 in 2.300% Senior Notes Due 2024 and $650,000,000 in 2.950% Senior Notes Due 2029

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 18, 2019-- LabCorp® (NYSE: LH) announced today that it has priced its offering of $1,050,000,000 in senior notes. The offering consists of two tranches: $400,000,000 aggregate principal amount of 2.300% Senior Notes due 2024 (the 2024 Notes) and $650,000,000

LabCorp Announces a Tender Offer for up to $300,000,000 Principal Amount of Its Outstanding 4.625% Senior Notes Due 2020

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 18, 2019-- LabCorp® (NYSE: LH) announced today that it has commenced a cash tender offer (the Offer) to purchase up to $300,000,000 principal amount (the Tender Cap) of its outstanding $600,000,000 aggregate principal amount of 4.625% Senior Notes due 2020

LabCorp Announces Proposed Sale of Senior Notes

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 18, 2019-- LabCorp® (NYSE: LH) announced today that it plans to offer, subject to market and other conditions, senior notes that are expected to be issued in two tranches (the Notes). The Notes will be senior unsecured obligations and will rank equally with